Lamellar Biomedical Ltd.

Lamellar Biomedical Ltd. Lamellar is developing a range of patent protected medical devices and pharmaceuticals based on mime

Lamellar are looking to recruit an associate for a 24 month KTP in partnership with Strathclyde Institute of Pharmacy an...
13/11/2018

Lamellar are looking to recruit an associate for a 24 month KTP in partnership with Strathclyde Institute of Pharmacy and Biomedical Sciences.


The position will provide the unique opportunity for an enthusiastic graduate to be instrumental in the formulation, development and characterisation of novel LAMELLASOME™ products.

November 13, 2018: Lamellar Biomedical Limited posted an article on LinkedIn

We've filed the patent for our versatile LAMELLASOME™ nucleic acid delivery platform and we now look forward to helping ...
01/11/2018

We've filed the patent for our versatile LAMELLASOME™ nucleic acid delivery platform and we now look forward to helping realise the potential of all kinds of nucleic acid therapeutics.

Lamellar Biomedical has filed a patent covering its unique and versatile LAMELLASOME™ platform for the safe and effective delivery of nucleic acid based therapeutics. The technology will play a key role in realising the potential of many of the nucleic acids in development, potentially revolutioni...

We are attending BIO-Europe 2018 in Copenhagen to introduce our cutting-edge LAMELLASOME™ technology that pioneers new a...
31/10/2018

We are attending BIO-Europe 2018 in Copenhagen to introduce our cutting-edge LAMELLASOME™ technology that pioneers new approaches for the safe and effective transfer of functional nucleic acids.

We are attending BIO-Europe 2018 in Copenhagen to introduce potential partners and investors to our cutting-edge LAMELLASOME™ technology that pioneers new approaches for the safe and effective transfer of functional nucleic acids.

08/05/2017

Lamellar Biomedical Raises £5.75m in Series C Fund Raising led by Invesco

Lamellar Biomedical, a biotechnology company developing a range of patent-protected medical and pharmaceutical products, based on LAMELLASOME™ technology, has raised £5.75 million in a Series C equity funding round. The financing was led by Invesco Asset Management Limited acting as agent for and on...

07/11/2016

Lamellar are recruiting for a Temporary Development Scientist! Deadline for applications: 05/12/16 http://shar.es/1I6T4r

If you've got the skills, we've got the country. Looking to move to Scotland or a company looking to expand? TalentScotland can help.

Our clinical study has officially started!
29/03/2016

Our clinical study has officially started!

“First patient recruited in Visco-ease RIX study: https://t.co/Lw8gh7RSzo ”

Vote lamellar
01/03/2016

Vote lamellar

Lamellar Biomedical have a unique product that potentiates new and old antibiotics. Animal models have produced excellent results for respiratory and ocular infections.

Address

Lamellar Biomedical
Motherwell
ML14WR

Telephone

+441698748832

Website

Alerts

Be the first to know and let us send you an email when Lamellar Biomedical Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Lamellar Biomedical Ltd.:

Shortcuts

Share

Category